Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Byrd

Showing results (351-360 of 1,058) with videos related to

Pageof 106
Sort By:
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 23, 2020
Tetrazole Azasydnone (C<sub>2</sub> N<sub>7</sub> O<sub>2</sub> H) And Its Salts: High-Performing Zwitterionic Energetic Materials Containing A Unique ExplosophoreMatthew L Gettings, Michael T Thoenen, Edward F C Byrd, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 5, 1997
Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatmentD J Shields, J C Byrd, S L Abbondanzo, et al.
British Journal of Haematology|May 8, 1999
Herpes virus infections occur frequently following treatment with fludarabine: results of a prospective natural history studyJ C Byrd, L H McGrail, D R Hospenthal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Pancreatitis during therapy of acute myeloid leukemia: cytarabine related?L H McGrail, L H Sehn, R B Weiss, et al.
Leukemia & Lymphoma|November 8, 2001
Carboxyamido-triazole (CAI)--a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cellsJ K Waselenko, C A Shinn, C R Willis, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 8, 2018
Cancer-Specific Stress and Trajectories of Psychological and Physical Functioning in Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaNeha G Goyal, Kami J Maddocks, Amy J Johnson, et al.
Cancer|July 1, 1996
Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumorR A Avery, J E Harris, C J Davis, et al.
Expert Review of Proteomics|April 2, 2014
Systems biology and proteomic analysis of cerebral cavernous malformationAlexander R Edelmann, Sarah Schwartz-Baxter, Christopher F Dibble, et al.
Leukemia & Lymphoma|March 28, 2019
Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance)Teresa L Deshields, Amylou C Dueck, Kerry Rogers, et al.
Leukemia & Lymphoma|July 30, 2019
A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemiaLeslie A Andritsos, John C Byrd, Peter Cheverton, et al.
Pageof 106

Showing results (351-360 of 1,058) with videos related to

Sort By:
Pageof 106
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 23, 2020
Tetrazole Azasydnone (C<sub>2</sub> N<sub>7</sub> O<sub>2</sub> H) And Its Salts: High-Performing Zwitterionic Energetic Materials Containing A Unique ExplosophoreMatthew L Gettings, Michael T Thoenen, Edward F C Byrd, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 5, 1997
Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatmentD J Shields, J C Byrd, S L Abbondanzo, et al.
British Journal of Haematology|May 8, 1999
Herpes virus infections occur frequently following treatment with fludarabine: results of a prospective natural history studyJ C Byrd, L H McGrail, D R Hospenthal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Pancreatitis during therapy of acute myeloid leukemia: cytarabine related?L H McGrail, L H Sehn, R B Weiss, et al.
Leukemia & Lymphoma|November 8, 2001
Carboxyamido-triazole (CAI)--a novel "static" signal transduction inhibitor induces apoptosis in human B-cell chronic lymphocytic leukemia cellsJ K Waselenko, C A Shinn, C R Willis, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 8, 2018
Cancer-Specific Stress and Trajectories of Psychological and Physical Functioning in Patients With Relapsed/Refractory Chronic Lymphocytic LeukemiaNeha G Goyal, Kami J Maddocks, Amy J Johnson, et al.
Cancer|July 1, 1996
Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumorR A Avery, J E Harris, C J Davis, et al.
Expert Review of Proteomics|April 2, 2014
Systems biology and proteomic analysis of cerebral cavernous malformationAlexander R Edelmann, Sarah Schwartz-Baxter, Christopher F Dibble, et al.
Leukemia & Lymphoma|March 28, 2019
Perceived risk for cancer progression and psychological status in chronic lymphocytic leukemia patients: CALGB 70603 (Alliance)Teresa L Deshields, Amylou C Dueck, Kerry Rogers, et al.
Leukemia & Lymphoma|July 30, 2019
A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemiaLeslie A Andritsos, John C Byrd, Peter Cheverton, et al.
Pageof 106